The promotion of angiogenesis by growth factors integrated with ECM proteins through coiled-coil structures

被引:46
作者
Assal, Yasmine [1 ]
Mie, Masayasu [1 ]
Kobatake, Eiry [1 ]
机构
[1] Tokyo Inst Technol, Dept Biol Informat, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268051, Japan
关键词
Extracellular matrix (ECM); Growth factor; Endothelial cell; Cell proliferation; Scaffold; Angiogenesis; MATRIX; LAMININ; ANGIOPOIETIN-2; CONSTRUCTION; EXPRESSION; ELASTIN; DESIGN; CHAIN; VEGF;
D O I
10.1016/j.biomaterials.2013.01.067
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
An appropriate method to bind extracellular matrix (ECM) proteins and growth factors using advanced protein engineering techniques has the potential to enhance cell proliferation and differentiation for tissue regeneration and repair. In this study we developed a method to co-immobilize non-covalently an ECM protein to three different types of growth factors: basic fibroblast growth factor (bFGF), epidermal growth factor (EGF) and single-chain vascular endothelial growth factor (scVEGF121) through a coiled-coil structure formed by helixA/helixB in order to promote angiogenesis. The designed ECM was established by fusing two repeats of elastin-derived unit (APGVGV)(12), cell-adhesive sequence (RGD), laminin-derived IKVAV sequence and collagen-binding domain (CBD) to obtain CBDEREI2. HelixA was fused to each growth factor and helixB to the engineered ECM. Human umbilical vein endothelial cells (HUVECs) were cultured on engineered ECM and growth factors connected through the coiled-coil formation between helixA and helixB. Cell proliferation and capillary tube-like formation were monitored. Moreover, the differentiated cells with high expression of Ang-2 suggested the ECM remodeling. Our approach of non-covalent coupling method should provide a protein-release control system as a new contribution in biomaterial for tissue engineering field. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3315 / 3323
页数:9
相关论文
共 30 条
[1]   Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization [J].
Asahara, T ;
Chen, DH ;
Takahashi, T ;
Fujikawa, K ;
Kearney, M ;
Magner, M ;
Yancopoulos, GD ;
Isner, JM .
CIRCULATION RESEARCH, 1998, 83 (03) :233-240
[2]   SYNTHESIS AND RGD PEPTIDE MODIFICATION OF A NEW BIODEGRADABLE COPOLYMER - POLY(LACTIC ACID-CO-LYSINE) [J].
BARRERA, DA ;
ZYLSTRA, E ;
LANSBURY, PT ;
LANGER, R .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1993, 115 (23) :11010-11011
[3]   Single-chain vascular endothelial growth factor variant with antagonist activity [J].
Boesen, TP ;
Soni, B ;
Schwartz, TW ;
Halkier, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (43) :40335-40341
[4]   NEW ARTIFICIAL CONNECTIVE MATRIX MADE OF FIBRIN MONOMERS, ELASTIN PEPTIDES AND TYPE I+III COLLAGENS - STRUCTURAL STUDY, BIOCOMPATIBILITY AND USE AS TYMPANIC MEMBRANES IN RABBIT [J].
BONZON, N ;
CARRAT, X ;
DEMINIERE, C ;
DACULSI, G ;
LEFEBVRE, F ;
RABAUD, M .
BIOMATERIALS, 1995, 16 (11) :881-885
[5]   Human corneal epithelial cell response to epidermal growth factor tethered via coiled-coil interactions [J].
Boucher, Cyril ;
Ruiz, Juan-Carlos ;
Thibault, Marc ;
Buschmann, Michael D. ;
Wertheimer, Michael R. ;
Jolicoeur, Mario ;
Durocher, Yves ;
De Crescenzo, Gregory .
BIOMATERIALS, 2010, 31 (27) :7021-7031
[6]   Angiogenesis in health and disease [J].
Carmeliet, P .
NATURE MEDICINE, 2003, 9 (06) :653-660
[7]   REACTIONS TO A BOVINE COLLAGEN IMPLANT - CLINICAL AND IMMUNOLOGICAL STUDY IN 705 PATIENTS [J].
CHARRIERE, G ;
BEJOT, M ;
SCHNITZLER, L ;
VILLE, G ;
HARTMANN, DJ .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1989, 21 (06) :1203-1208
[8]  
Cook AD, 1997, J BIOMED MATER RES, V35, P513
[9]   Construction of epidermal growth factor fusion protein with cell adhesive activity [J].
Elloumi, I ;
Kobayashi, R ;
Funabashi, H ;
Mie, M ;
Kobatake, E .
BIOMATERIALS, 2006, 27 (18) :3451-3458
[10]  
FOLKMAN J, 1992, J BIOL CHEM, V267, P10931